AI-generated analysis. Always verify with the original filing.
AstraZeneca PLC notified the admission to trading on the London Stock Exchange Main Market of 45,750 additional ordinary shares (ISIN: GB0009895292) issued under employee share schemes from 20 January 2026 to 19 March 2026, under a block admission dated 29 January 2021. Total ordinary shares in issue following admission: 1,550,980,332.